Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer
GeriPal
MARCH 2, 2023
And for that reason, there was actually an enormous lawsuit, and the manufacturer was fined, now I think 20 years ago, in the millions and millions of dollars for off-label prescribing. There was this big thing called the CMS National Partnership to Improve Dementia Care, started in 2012. But yes, they’re both increasing.
96 
Let's personalize your content